ArticleThe American journal of pathology2010

Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.

Mark E Stearns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.